World Cardiac Biomarkers - Market Opportunities and Forecasts, 2014 -2020 .pdf

The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarkertesting is the profound approach for obtaining rapid results for immediate diagnosing andtreatment. Cardiac biomarkers are protein-based traceable substances used as an indicator ofbiologic state and used for diagnostic and prognostic purposes associated with heart. Cardiacbiomarkers are used as risk stratification for various cardiovascular diseases (CVDs), whichinclude myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) amongothers. The cardiac biomarkers that are widely used as an integrated diagnostic approach forCVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others.Ability of cardiac biomarkers for accurate and rapid prediction of heart failure after the onset ofchest pain has added boost to the market growth. In addition, promising features such as highaccuracy, quick outcomes and economic pricing of cardiac point of care (POC) testing is drivingthe growth of cardiac biomarker market, globally. To keep the momentum of cardiac biomarker,the key manufacturers offers customized solutions. The commercial application of multi-menuoptions for cardiac testing using different combinations of cardiac biomarkers and targetorientedsolutions are the key opportunities of the cardiac biomarker market. However, limitedspecificity in some cases and side effects such as skeletal muscle injury are some of the factorsrestraining the growth cardiac biomarkers markets.Get Full Access for the Report at: https://www.alliedmarketresearch.com/cardiac-biomarkersmarketBased on geography, the global cardiac biomarker market is segmented into North America,Europe, Asia-Pacific and LAMEA. North America leads the global cardiac biomarker market,owing to the high demand for cardiac testing, high CVD prevalence rate and growing awarenesstowards cardiac diagnostics solutions. Asia-Pacific is growing at the fastest CAGR due to themodernization, increasing disposable incomes and rising affordability for the advanced cardiactreatments.Key companies profiled in this market include Roche Diagnostics, Abbott Laboratories, SiemensHealthcare, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux,Randox laboratories, Beckman Coulter and Thermo Fisher Scientific. Product launch andtechnological advancements are the few strategies adopted by the key players of global cardiacbiomarker market. The companies are currently focusing on innovative technologies such asautomated, multi-assay using combinations of cardiac biomarkers and point-of-care cardiacbiomarker devices.© ALLIED MARKET RESEARCH

KEY BENEFITS: Extensive coverage of the global cardiac biomarker market including drivers, restraintsand opportunities would help professionals to better understand the market behaviour Country level analysis has been done to provide micro market sizing of cardiac biomarkerin different regions The market estimations are made in the report by conducting high-end analysis of thekey market segments for the period of 2014-2020 A comprehensive analysis of the market scenario in terms of types, applications, locationof testing and geography helps identify the growth opportunities in the global cardiacbiomarker market The market attractiveness analysis for the Global cardiac biomarker market providesstrategic assistance to the decision makersKey market players within the global cardiac biomarker market are profiled in the report andtheir strategies are analysed thoroughly, which helps in understanding competitive outlook ofthis marketKEY MARKET SEGMENTSGlobal Cardiac biomarker market is segmented into type, application, location of testing andgeography.Global Cardiac Biomarker Market – By Type Myocardial muscle Creatine Kinase (CK-MB) Troponins (T and I) Myoglobin Brain Natriuretic Peptide (BNPs) or NT-proBNP Ischemia Modified Albumin (IMA) OthersGlobal Cardiac Biomarker Market – By Application Myocardial Infarction Congestive Heart Failure Acute Coronary Syndrome Atherosclerosis Others© ALLIED MARKET RESEARCH

Global Cardiac Biomarker Market – By Location of testing Point of care testing Laboratory testingGlobal Cardiac Biomarker Market – By Geography North Americao U.S.o Canadao Mexico Europeo Franceo Germanyo U.K. Asia-Pacifico Japano Indiao Chinao Australiao Others LAMEAo Latin Americao Middle Easto Africa© ALLIED MARKET RESEARCH

About Us:Allied Market Research (AMR) is a full-service market research and business-consulting wing ofAllied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprisesas well as medium and small businesses with unmatched quality of "Market Research Reports"and "Business Intelligence Solutions". AMR has a targeted view to provide business insights andconsulting to assist its clients to make strategic business decisions and achieve sustainable growthin their respective market domain.We are in professional corporate relations with various companies and this helps us in diggingout market data that helps us generate accurate research data tables and confirms utmostaccuracy in our market forecasting. Each and every data presented in the reports published by usis extracted through primary interviews with top officials from leading companies of domainconcerned. Our secondary data procurement methodology includes deep online and offlineresearch and discussion with knowledgeable professionals and analysts in the industry.Contact Us:David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesInt'l: +1 (503) 505-6949Toll Free: + 1-800-792-5285 (U.S. & Canada)E-mail: sales@alliedmarketresearch.comWeb: http://www.alliedmarketresearch.com/© ALLIED MARKET RESEARCH